Materias dentro de su búsqueda.
Mostrando 5,201 - 5,220 Resultados de 5,950 Para Buscar 'Hanussen~', tiempo de consulta: 1.82s Limitar resultados
  1. 5201
    “…INTRODUCTION: PF-06438179, a potential biosimilar to Remicade(®) (infliximab, Janssen Biotech, Inc.), is a chimeric mouse–human monoclonal antibody targeting human tumor necrosis factor alpha (TNF). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Nonclinical Evaluation of PF-06438179: A Potential Biosimilar to Remicade(®) (Infliximab)
  2. 5202
    “…Cite this article: J.W.A.M. den Teuling, B.S. Pauwels, L. Janssen, C.E. Wyers, H. M. J. Janzing, J.P.W. van den Bergh, J. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The influence of bone mineral density and cortical index on the complexity of fractures of the proximal humerus
  3. 5203
    “…DISCLOSURES: J. Veltman, Janssen: Speaker’s Bureau, Speaker honorarium.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2254. Adherence to Cardiovascular Disease Risk Management Guidelines Amongst HIV Providers at an Academic HIV Clinic
  4. 5204
    “…Henckens MJMJ, de Vries P, Janssen E, et al. Associations of Affect, Action Readiness, and Sexual Functioning. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Associations of Affect, Action Readiness, and Sexual Functioning
  5. 5205
    “…At the policy level, they are currently supporting safe back-to-work policies at a major institution and vaccine trial location planning at Janssen Pharmaceuticals, and have been integrated into the US Center for Disease Control’s pandemic forecast. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    From predictions to prescriptions: A data-driven response to COVID-19
  6. 5206
    “…METHODS: Plasma was collected from 22 health care worker controls, 81 patients with IEIs, and 2 patients with thymoma; the plasma was collected before immunization, 1 to 6 days before the second dose of mRNA vaccine, and at a median of 30 days after completion of the immunization schedule with either mRNA vaccine or a single dose of Johnson & Johnson’s Janssen vaccine. Anti-spike (anti-S) and anti-nucleocapsid antibody titers were measured by using a luciferase immunoprecipitation systems method. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Antibody responses to the SARS-CoV-2 vaccine in individuals with various inborn errors of immunity
  7. 5207
    por Sattui, Sebastian Eduardo, Liew, Jean W, Kennedy, Kevin, Sirotich, Emily, Putman, Michael, Moni, Tarin T, Akpabio, Akpabio, Alpízar-Rodríguez, Deshiré, Berenbaum, Francis, Bulina, Inita, Conway, Richard, Singh, Aman Dev, Duff, Eimear, Durrant, Karen L, Gheita, Tamer A, Hill, Catherine L, Howard, Richard A, Hoyer, Bimba F, Hsieh, Evelyn, El Kibbi, Lina, Kilian, Adam, Kim, Alfred Hyoungju, Liew, David F L, Lo, Chieh, Miller, Bruce, Mingolla, Serena, Nudel, Michal, Palmerlee, Candace A, Singh, Jasvinder A, Singh, Namrata, Ugarte-Gil, Manuel Francisco, Wallace, John, Young, Kristen J, Bhana, Suleman, Costello, Wendy, Grainger, Rebecca, Machado, Pedro M, Robinson, Philip C, Sufka, Paul, Wallace, Zachary S, Yazdany, Jinoos, Harrison, Carly, Larché, Maggie, Levine, Mitchell, Foster, Gary, Thabane, Lehana, Rider, Lisa G, Hausmann, Jonathan S, Simard, Julia F, Sparks, Jeffrey A
    Publicado 2021
    “…Types of COVID-19 vaccines were Pfizer-BioNTech (53.2%), Oxford/AstraZeneca (22.6%), Moderna (21.3%), Janssen/Johnson & Johnson (1.7%) and others (1.2%). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey
  8. 5208
    “…Our model indicates considerable uncertainty in Oxford-AstraZeneca ChAdOx1 and Janssen Ad26.COV2.S VE against any infection, with slightly higher than published, bias-adjusted values of 59.0% (95% uncertainty interval [UI] 38.4–77.1) and 70.9% (95% UI 49.8–80.7), respectively. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Measuring Vaccine Efficacy Against Infection and Disease in Clinical Trials: Sources and Magnitude of Bias in Coronavirus Disease 2019 (COVID-19) Vaccine Efficacy Estimates
  9. 5209
    “…Cerebral venous and sinus thrombosis (CVST) after adenovirus-vectored COVID-19 ChAdOx1 nCov-19 (Oxford–AstraZeneca) and Ad26.COV2.S (Janssen/Johnson & Johnson) is a rare complication, occurring mainly in individuals under 60 years of age and more frequently in women. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Cerebral venous sinus thrombosis after adenovirus-vectored COVID-19 vaccination: review of the neurological-neuroradiological procedure
  10. 5210
    por Kissling, Esther, Hooiveld, Mariëtte, Martínez-Baz, Iván, Mazagatos, Clara, William, Naoma, Vilcu, Ana-Maria, Kooijman, Marjolein N, Ilić, Maja, Domegan, Lisa, Machado, Ausenda, de Lusignan, Simon, Lazar, Mihaela, Meijer, Adam, Brytting, Mia, Casado, Itziar, Larrauri, Amparo, Murray, Josephine-L K, Behillil, Sylvie, de Gier, Brechje, Mlinarić, Ivan, O’Donnell, Joan, Rodrigues, Ana Paula, Tsang, Ruby, Timnea, Olivia, de Lange, Marit, Riess, Maximilian, Castilla, Jesús, Pozo, Francisco, Hamilton, Mark, Falchi, Alessandra, Knol, Mirjam J, Kurečić Filipović, Sanja, Dunford, Linda, Guiomar, Raquel, Cogdale, Jade, Cherciu, Carmen, Jansen, Tessa, Enkirch, Theresa, Basile, Luca, Connell, Jeff, Gomez, Verónica, Sandonis Martín, Virginia, Bacci, Sabrina, Rose, Angela MC, Pastore Celentano, Lucia, Valenciano, Marta, Čusek Adamić, Katica, Ferenčak, Ivana, Kaić, Bernard, Kosanović Ličina, Mirjana Lana, Lakošeljac, Danijela, Mihin Huskić, Ivana, Nonković, Diana, Andrews, Nick, Lopez Bernal, Jamie, Ellis, Joanna, Whitaker, Heather, Blanchon,, Thierry, Guerrisi,, Caroline, Launay,, Titouan, Masse,, Shirley, van der Werf, Sylvie, Enouf, Vincent, Cuddihy, John, O’Connor, Lois, McKenna, Adele, Joyce, Michael, de Gascun, Cillian, Moran, Joanne, van Gageldonk-Lafeber, Rianne, Hahné, Susan J, de Melker, Hester E, Fanoy, Ewout B, Raven, Stijn, Middeldorp, Marit, Kislaya, Irina, Nunes, Baltazar, Roquete, Rita, Silva, Adriana, Melo, Aryse, Costa, Inês, Verdasca, Nuno, Conde, Patrícia, Soeiro, Amélia, Mihai, Maria Elena, Bistriceanu, Iulia, Ivanciuc, Alina, Dintoi, Diana, Pascu, Catalina, Jidovu, Adrian, Sigerson, Debbie, Marques, Diogo FP, Molesworth, Anna, Quinn, Leanne, Leyton, Miranda, Campbell, Selin, Thoulass, Janine, McMenamin, Jim, Casas Flecha, Inmaculada, Martínez Mateo, Ana, Castrillejo, Daniel, Martínez Ochoa, Eva María, Quiñones Rubio, Carmen, Delgado-Sanz, Concepción, Oliva, Jesús, Miqueleiz, Ana, Navascués, Ana, Trobajo-Sanmartín, Camino, Ezpeleta, Carmen, López Moreno, Paula, Gorricho, Javier, Ardanaz, Eva, Baigorria, Fernando, Barricarte, Aurelio, Burgui, Cristina, de la Cruz, Enrique, Egüés, Nerea, García Cenoz, Manuel, Guevara, Marcela, Moreno-Iribas, Conchi, Sayón, Carmen, Penttinen, Pasi, Carstairs, Christiana
    Publicado 2022
    “…VE among those aged 30–59 years was 78% (95% CI: 75–81), 66% (95% CI: 58–73), 91% (95% CI: 87–94) and 52% (95% CI: 40–61), for Comirnaty, Vaxzevria, Spikevax and COVID-19 Vaccine Janssen, respectively. VE among people 60 years and older was 67% (95% CI: 52–77), 65% (95% CI: 48–76) and 83% (95% CI: 64–92) for Comirnaty, Vaxzevria and Spikevax, respectively. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe: multicentre analysis, I-MOVE-COVID-19 and ECDC networks, July to August 2021
  11. 5211
    “…FUNDING: Unconditional educational grant from Janssen.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Mortality-causing mechanisms and healthcare resource utilisation of treatment-resistant depression: A six-year population-based cohort study
  12. 5212
    “…DISCLOSURE: Ursula Werneke has received funding for educational activities on behalf of Norrbotten Region (Masterclass Psychiatry Programme 2014-2018 and EAPM 2016, Luleå, Sweden): Astra Zeneca, Eli Lilly, Janssen, Novartis, Otsuka/Lundbeck, Servier, Shire and Sunovi…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Death associated with coronavirus (COVID-19) infection in individuals with severe mental disorders in sweden during the early months of the outbreak
  13. 5213
    “…DISCLOSURE: MO: scient adv. board member Astra Zeneca Sweden; UW: educ. activities Norrbotten Region: Astra Zeneca, Eli Lilly, Janssen, Novartis, Otsuka/Lundbeck, Servier, Shire and Sunovion. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Lithium-associated hypothyroidism: Reversible after lithium discontinuation?
  14. 5214
    “…Werneke: received funding for educational activities on behalf of Norrbotten Region; Astra Zeneca, Eli Lilly, Janssen, Novartis, Otsuka/Lundbeck, Servier, Shire, Sunovion. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Monoaminoxidase inhibitors as a cause of serotonin syndrome – a systematic case review based on meta-analytic principles
  15. 5215
    por Young, A.
    Publicado 2021
    “…DISCLOSURE: Paid lectures and advisory boards for the following companies with drugs used in affective and related disorders: Astrazenaca, Eli Lilly, Lundbeck, Sunovion, Servier, Livanova, Janssen, Allegan, Bionomics, Sumitomo Dainippon Pharma, COMPASS Principal Inve…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Bipolar affective disorder
  16. 5216
    por Mcloughlin, D., Fox, C.
    Publicado 2021
    “…McLoughlin has received speaker’s honoraria from Mecta and Otsuka and an honorarium from Janssen for participating in an esketamine advisory board meeting. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Effect of electrode placement on speed of response to ECT
  17. 5217
    “…CONFLICT OF INTEREST: AGR has received honoraria, registration for congresses and/or travel costs from Janssen, Lundbeck-Otsuka and Angelini.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Impact of day hospital care on adherence to psychiatric follow-up appointments and medications in patients with delusional disorder
  18. 5218
    “…Data reported by French psychiatrists are the first collected in this specific population and provide descriptive information on patient characteristics, burden of disease; Esketamine management and practical use at hospital level DISCLOSURE: Data analysis performed by RCTs and poster conception coordinated by Medergy and funded by Janssen…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Esketamine in patient with treatment resistant depression: Outcome of the temporary authorization for use programme in France
  19. 5219
    “…The study was performed when the Center for Disease Control and Prevention (CDC) recommended two doses of Pfizer/BioNTech [BNT162b2] and Moderna [mRNA-1273 SARS-CoV-2] vaccine or 1 dose Johnson & Johnson/Janssen [Ad26.COV2·S] vaccines for full vaccination in transplant recipients. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Development of donor specific antibodies after SARS-CoV-2 vaccination in kidney and heart transplant recipients
  20. 5220
    “…DISCLOSURE: AG has received travel and financial support from Janssen, Otsuka-Lundbeck and Angelini, and research support from Instituto de Salud Carlos III, and declares no support related with the subject of this presentation.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Emergency Psychiatry before and during COVID-19 pandemia
Herramientas de búsqueda: RSS